Gritstone 4+6

This study is testing a new vaccine, known as GRT-R910, to be used as a booster to prevent coronavirus infection (COVID-19)

It is sponsored by Gritstone bio, Inc and is being carried out by a team of researchers at Manchester University NHS Foundation Trust

This study has ended and is currently not accepting new applicants.

Trial ID

  • NCT05148962

Share this study

Research for the Future
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.